ISRCTN49873657已完成不适用
A double blind, randomised, vehicle-controlled, safety and tolerance study of topical PSK 3841 solution at 5% administered twice daily over four weeks to healthy Caucasian males with androgenetic alopecia
ProStrakan Pharmaceuticals (France)0 个研究点目标入组 60 人开始时间: 2005年10月6日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •For male subjects:
- •1. Caucasian healthy male subjects aged between 18 and 50 years old with an androgenic alopecia graded as IIIa, IIIv, IV, IVa or V according to Norwood-Hamilton classification
- •2. Subjects cohabiting with their female partner during all the study treatment
- •For their female partners:
- •1. Healthy female subjects
排除标准
- •For male subjects:
- •1. Mobile working activities preventing sleeping at home on a regular basis
- •2. Baldness due to medical illness, alopecia aerata, trichotillomania or any other form of pathologic alopecia other than androgenetic alopecia
- •3. Any pathology or abnormality of the skin in the areas to be treated
- •4. History of skin allergy
- •5. Regular use of medication which might interfere with the results of the study
- •For their female partners:
- •1. Mobile working activities preventing sleeping at home on a regular basis
- •2. Pregnant or lactating female
- •3. Female of childbearing potential without adequate efficacious contraception
研究者
相似试验
进行中（未招募）
1 期
A double-blind, randomized, vehicle-controlled clinical multi-center study to evaluate the efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel, 2 and 5%, applied once daily for 12 weeks in patients with facial acne vulgarisfacial acne vulgarisMedDRA version: 20.0Level: PTClassification code 10000496Term: AcneSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2018-003307-19-DEPPM SERVICES S.A.450
进行中（未招募）
1 期
A double-blind, randomized, vehicle-controlled clinical multi-center study to evaluate the efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel, 2 and 5%, applied once daily for 12 weeks in patients with facial acne vulgarisfacial acne vulgarisMedDRA version: 20.0Level: PTClassification code 10000496Term: AcneSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2018-003307-19-ITPPM SERVICES S.A.450
进行中（未招募）
1 期
A double-blind, randomized, vehicle-controlled clinical multi-center study to evaluate the efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel, 2 and 5%, applied once daily for 12 weeks in patients with facial acne vulgarisfacial acne vulgarisMedDRA version: 20.0Level: PTClassification code 10000496Term: AcneSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2018-003307-19-PLPPM SERVICES S.A.450
进行中（未招募）
1 期
A randomised, double-blind, vehicle controlled, single centre, parallel group, comparative study of the efficacy of penciclovir 10 mg/g (1%) cream in preventing the appearance of classical lesions in recurrent cold sore sufferers. - Penciclovir 1% Cream Efficacy StudyCold Sores caused by the herpes simplex virus (HSV) type 1.MedDRA version: 9.1 Level: LLT Classification code 10049352 Term: Cold sores lipEUCTR2007-004316-31-GBovartis Consumer Health S.A.
进行中（未招募）
不适用
A randomized, double-blind, vehicle-controlled, half-side comparison, monocenter, clinical study evaluating the efficacy and safety of a herbal dermatitis ointment for the treatment of mild to moderate atopic dermatitisatopic dermatitisEUCTR2004-002594-23-DEWeber & Weber GmbH & Co.KG